Brevan Howard Capital Management LP
Institutional investor · Portfolio as of Q2 2016
Top Holdings5 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
STATE STREET SPDR S&P 500 ETF TRUST CL USD INC | 3.7M | $775.1M | 84.9% | — | — | — | Increased — |
ISHARES MSCI EMERGING MARKETS INDEX FUND | 3M | $103.1M | 11.3% | — | — | — | New — |
ISHARES MSCI EMERGING MARKETS INDEX FUND | 728,862 | $25M | 2.7% | $27.46 | +0.04% | 2 qtrssince 2016-Q1 | Decreased 0 |
CME GROUP INC | 102,553 | $10M | 1.1% | $66.47 | +1.17% | 2 qtrssince 2016-Q1 | Unchanged 0 |
OCWEN FINL CORP | 118,915 | $203,000 | 0.0% | — | — | 2 qtrssince 2016-Q1 | Unchanged 0 |
Brevan Howard Capital Management LP manages $913.4M across 5 positions as of Q2 2016. Top holdings: SPY (84.9%), EEM (11.3%), EEM (2.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.
Active quarter - 0 new positions, 10 exits, 0 increased. No standout high-conviction moves this quarter. Portfolio: $913M across 5 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer